A randomized phase II trial of ERCC1 and RRM1 mRNA expression-based chemotherapy versus docetaxel/carboplatin in advanced non-small cell lung cancer
2016 ◽
Vol 77
(3)
◽
pp. 539-548
◽
Keyword(s):
Phase Ii
◽